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A better understanding of how antibiotic exposure impacts the
evolution of resistance in bacterial populations is crucial for design-
ing more sustainable treatment strategies. The conventional ap-
proach to this question is to measure the range of concentrations
over which resistant strain(s) are selectively favored over a sensitive
strain. Here, we instead investigate how antibiotic concentration
impacts the initial establishment of resistance from single cells,
mimicking the clonal expansion of a resistant lineage following
mutation or horizontal gene transfer. Using two Pseudomonas aer-
uginosa strains carrying resistance plasmids, we show that single
resistant cells have <5% probability of detectable outgrowth at an-
tibiotic concentrations as low as one-eighth of the resistant strain’s
minimum inhibitory concentration (MIC). This low probability of es-
tablishment is due to detrimental effects of antibiotics on resistant
cells, coupled with the inherently stochastic nature of cell division
and death on the single-cell level, which leads to loss of many na-
scent resistant lineages. Our findings suggest that moderate doses
of antibiotics, well below the MIC of resistant strains, may effec-
tively restrict de novo emergence of resistance even though they
cannot clear already-large resistant populations.
antimicrobial resistance | Pseudomonas aeruginosa | inoculum effect |
mathematical model | extinction probability
Antibiotics have had a huge impact on human health by re-ducing the burden associated with bacterial infections, and
the use of antibiotics now underpins many areas of medicine.
Unfortunately, antibiotic treatment is also associated with the
evolution of resistance (1), resulting in poorer patient outcomes
(2). A better understanding of how antibiotic dosing affects re-
sistance evolution could aid the design of more effective treat-
ment strategies that suppress pathogenic bacteria while reducing
the risk of emergence of resistance.
Susceptibility of a bacterial strain to a particular antibiotic is
typically quantified by the minimum inhibitory concentration
(MIC), the lowest antibiotic concentration that prevents growth
of this strain in a standardized assay, such as in ref. 3. Here, we
will refer to any strain with reduced susceptibility relative to a
reference “sensitive” strain simply as “resistant,” as is common in
evolutionary microbiology literature (e.g., refs. 4–6), as opposed
to defining resistance with respect to clinical breakpoints. Al-
though antibiotic dosing strategies initially focused only on effi-
cacy against sensitive bacteria (7), the past two to three decades
have seen development of a large body of work investigating how
antibiotic exposure affects emergence of resistance (8, 9). A
prominent concept is that preexisting resistant subpopulations
will be selectively enriched within a particular range of antibiotic
concentrations, an idea first proposed in the 1990s (10–12), then
refined by the definition of the “mutant prevention concentra-
tion” giving the upper bound of this range (13) and further de-
veloped into the “mutant selection window” (MSW) hypothesis
(14–16). This hypothesis predicts that outgrowth of resistance
occurs at antibiotic concentrations ranging between the MIC of
the sensitive strain (which we denote MICS) and the mutant
prevention concentration, which is approximated by the MIC of
the most resistant single-step mutant (16). The MSW hypothesis
has gained support from in vitro and animal model studies, and
has been extended to consider time-varying drug concentrations
(reviewed in ref. 17).
The MSW is defined by thresholds in absolute fitness (growth
rates) of each strain in isolation, i.e., their MIC values. In evolu-
tionary biology, however, selection refers to changes in propor-
tions of genotypes in a population according to their differences in
fitness relative to one another. Direct competition experiments
have shown that resistant strains can have a competitive fitness
advantage over sensitive strains, even at concentrations well below
MICS (4, 11, 12, 18, 19). Thus, resistance can be selectively favored
over a potentially very wide range of antibiotic concentrations (5),
from concentrations considered too low to have any clinical benefit
(below MICS), up to concentrations above the MIC of a resistant
strain (MICR) that may be too high to achieve in clinical practice,
because of physiological constraints on the accumulation of antibi-
otics in tissues (pharmacokinetics) and/or toxic side effects (20–22).
Selection operates efficiently when both sensitive and resistant
populations are large, resulting in an increase in relative frequency
of the fitter strain. Correspondingly, selection coefficients are
typically measured by competition between large numbers of cells
(typically >104 colony-forming units [CFU]) of both resistant and
sensitive strains across a gradient of antibiotic concentrations (e.g.,
ref. 18). However, the de novo emergence of resistant strains
should be subject to stochastic processes (23) that are not captured
by the aforementioned experiments. First, resistance must sto-
chastically arise in a sensitive cell by mutation, genomic instability
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(24), or acquisition of a resistance gene through horizontal gene
transfer. Next, the single resistant cell thus generated must survive
and successfully divide to produce daughter cells that likewise sur-
vive, and so on to generate a large number of resistant descendant
cells. The latter process, which we will refer to throughout as “es-
tablishment” of resistance (23), will be our focus here. Importantly,
due to the stochastic nature of cell divisions and deaths on the in-
dividual cell level, establishment is not guaranteed, even if the re-
sistant strain has positive expected growth rate and a selective
advantage over the sensitive strain (25). In particular, if antibiotics
partially inhibit the resistant strain below its MICR, in the sense of
increasing the chance that a resistant cell dies or fails to divide
(i.e., decreasing absolute fitness), then the risk that a resistant
lineage is stochastically lost should increase with antibiotic con-
centration, despite its selective (i.e., relative fitness) advantage.
Despite the substantial body of work addressing the selection of
resistance, very little experimental work has addressed the sto-
chastic establishment phase (see, however, refs. 26–28).
We set out to quantify stochastic establishment in vitro in
Pseudomonas aeruginosa, an important opportunistic pathogen
that evolves resistance at an exceptionally high rate during in-
fections (1, 29). To isolate the establishment phase, we inocu-
lated hundreds of cultures, each with a very small number of
resistant cells (on average, ∼1 to 3), and assessed culture growth.
We tested two strains carrying nonconjugative plasmids (Rms149
and PAMBL2) that confer resistance to streptomycin and mer-
openem, respectively, across a range of antibiotic concentrations
below the corresponding MICR. By fitting mathematical models
to these data, we estimated the probability of establishment,
i.e., of detectable culture growth due to clonal expansion from a
single resistant cell, as a function of antibiotic concentration. Our
key finding is that the establishment probability of resistant cells
drastically declines at concentrations well below the MIC of the
resistant strain, reaching K 5% at one-eighth of MICR in both
systems. This result can be reconciled with the standard definition
of the MIC through a simple quantitative relationship between
inoculum size and probability of population growth (experimen-
tally validated in the streptomycin system). Our results highlight
that antibiotic selection pressure is not a sufficient condition for de
novo emergence of resistance starting from single cells; it is also
crucial to account for demographic stochasticity when evaluating
the impact of dosing strategies on emergence of resistance. Our
results suggest that lower antibiotic doses than those required to
clear large resistant populations (i.e., sub-MICR) may be effective,
with high probability, when resistant mutants are initially rare.
Results
Establishment of Resistance Is Inhibited by Sub-MICR Antibiotic
Concentrations. To elucidate the direct impact of antibiotics on
resistant cells, we first investigated establishment of a resistant
strain in the absence of a sensitive strain. We first focused on the
streptomycin-resistant PA01:Rms149 strain. To estimate its probabil-
ity of establishment, defined as outgrowth of a detectable (i.e., large)
population from a single cell, we conducted large-scale “seeding”
experiments (see also ref. 28). In this assay (Fig. 1), a highly di-
luted overnight culture of the resistant strain is inoculated into
fresh media in a large number of replicate cultures. The high di-
lution factors yield average inoculum sizes of <1 to ∼3 cells per
culture. Importantly, however, the actual number of cells inocu-
lated into each replicate culture is random, and can be described
by a Poisson distribution (SI Appendix, Fig. S1). One implication
of this protocol is that many cultures are not inoculated with any
cells, while others receive more than one cell; our modeling ap-
proach will account for this variation statistically. We inoculated
parallel replicate cultures in streptomycin-free media and at a
range of streptomycin concentrations below the MIC of the re-
sistant strain, denoted MICR, as measured using standard proto-
cols with larger inoculum size (ref. 3) (SI Appendix, Table S1). We
then scored the number of replicate cultures showing growth
based on reaching a threshold optical density (OD) of 0.1 within
3 d postinoculation.
A culture could fail to grow either because the inoculum did
not contain any cells, or because every cell in the inoculum failed
to give rise to a surviving lineage. To infer the probability that a
single cell yields detectable population growth (i.e., the per-cell
establishment probability), we fit a mathematical model, accounting
for both the random inoculum size and demographic stochasticity,
to the observed number of replicate cultures showing growth
Fig. 1. Design of seeding experiments to estimate establishment probability. An overnight culture of the resistant strain is highly diluted and used to in-
oculate 96-well plates containing growth media (LB broth) with antibiotic at various concentrations (shades of blue). The number of cells inoculated per well
follows a Poisson distribution (examples plotted for mean inoculum size of 0.5, 1, or 2 cells per well). Within these culture wells, stochastic population dy-
namics imply that each inoculated cell may either produce a large number of descendants (establishment) or produce no/few descendants that ultimately die
out (failure to establish). Plates are incubated for 3 d, and optical density is measured to score growth in wells (OD595 > 0.1; dark green). The number of
replicate cultures showing growth is used to estimate the per-cell establishment probability at each antibiotic concentration by fitting a mathematical model.
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(Materials and Methods). All probabilities are normalized by the
result in streptomycin-free media, which corresponds to scaling
inoculum size by the mean number of cells that establish in
benign conditions (which we call the “effective” inoculum size).
Thus, relative establishment probability ~pc equals 1 by defini-
tion in streptomycin-free conditions, while we expect ~pc ≤ 1 with
streptomycin treatment; however, values larger than 1 can arise
due to sampling error.
Our seeding experiments revealed that the probability of estab-
lishment of a single resistant cell declines with increasing strepto-
mycin concentration (Fig. 2 and SI Appendix, Table S2). While
exposure to the lowest tested concentrations of streptomycin (up to
1/32 × MICR) had no detectable impact on establishment, 1/16 ×
MICR was already sufficient for significant declines, to ~pc of 55 to
73% (maximum-likelihood estimates in two independent experi-
ments). At 1/8 × MICR, ~pc dropped to just 3 to 5%. These results
suggest that a resistant mutant would only rarely establish at anti-
biotic concentrations that are well below its MICR.
MIC Depends on Inoculum Size. The frequent failure of the resistant
strain to grow in our seeding experiments at concentrations well
below its MIC is, at face value, surprising. We hypothesized that
these results could be explained by the difference in inoculum
size between these assays. Specifically, standard MIC values are
assessed from an inoculation density of 5 × 105 CFU/mL (3),
which corresponds to an inoculum size of 105 CFU per 200-μL
culture on our microtiter plates. In contrast, our seeding exper-
iments used an inoculum size on the order of 1 CFU per culture.
MIC for many antibiotics has been observed to increase with
higher-than-standard inoculation densities (CFU/ml) (30–32),
which corresponds to higher absolute inoculum size (in CFU) for
a fixed culture volume. Although less well explored, it has also
occasionally been noted that MIC can decrease when lower ab-
solute inoculum sizes are used (33, 34).
To test the hypothesis that inoculum size influences MIC in
the present system, we conducted a modified MIC assay using
the PA01:Rms149 strain with inoculum sizes ranging over three
orders of magnitude, from ∼102 to 105 CFU per culture (cor-
responding to inoculation densities of 5 × 102 up to the standard
5 × 105 CFU/mL). We found that MIC indeed increases with
inoculum size (Fig. 3A). This pattern arises regardless of whether
growth is scored at 20 h, as per the standard MIC assay protocol
(3), or up to 3 d postinoculation, as in our seeding experiments,
although the number of cultures showing detectable growth, and
thus the measured MIC, tends to increase over time (SI Ap-
pendix, Fig. S2).
Since all cultures contained the same volume in the above ex-
periment, this pattern could be due to changes either in absolute
inoculum size (i.e., CFU) or in inoculation density (i.e., CFU per
unit volume). These two possibilities are not typically distin-
guished in the literature; however, they lead to distinct interpre-
tations. If demographic stochasticity is the dominant force, we
expect absolute numbers to matter, whereas if interactions among
cells (e.g., competition or cooperation) affect establishment, cell
density per unit volume could be more important. To disentangle
these two factors, we repeated the MIC assay covarying inocula-
tion density and culture volume. This experiment confirmed that
absolute inoculum size has a strong effect on MIC. In contrast,
inoculation density per unit volume does not have a significant
effect within the range that we tested, after controlling for abso-
lute cell numbers (SI Appendix, Fig. S3).
Population Growth Can Be Explained by an Independent Chance of
Each Cell to Establish. Taken together, our seeding experiments
and MIC assays reveal that the absolute number of cells in the
inoculum has a strong effect on whether the culture eventually
shows detectable growth. The simplest explanation for this result
is that population growth can be attributed to the stochastic
outgrowth of one or more lineages, each initiated by a single cell
in the inoculum, acting independently. This independence as-
sumption yields a “null model” that mathematically describes the
effect of inoculum size on the probability of outgrowth of a de-
tectable population (Materials and Methods and Eq. 1). Here, the
probability of establishment of each cell in the inoculum (~pc) is a
scaling parameter, which does not depend on inoculum size.
Note that this null model would not hold if interactions among
cells substantially influence their chances of successful replica-
tion. For example, if cells secrete an enzyme that breaks down an
antibiotic extracellularly, then the establishment probability of
each cell could increase with inoculum size. On the other hand, if
cells compete for limiting resources or secrete toxins, the per-cell
establishment probability could decrease with inoculum size.
To formally test the null model, we again conducted seeding
experiments with the PA01:Rms149 strain, but now using many
different inoculum sizes, spanning approximately three orders of
magnitude. We tested two streptomycin concentrations (1/16 and
1/8 × MICR) for which growth often failed from a single cell but
succeeded from standard inoculum size in MIC assays. In par-
allel, we tested growth in streptomycin-free media in order to
estimate the effective mean inoculum size (SI Appendix, Fig. S4).
This left one free parameter, the per-cell relative establishment
probability (~pc), to fit at each streptomycin concentration.
We found good agreement between the null model and our ex-
perimental data at all tested streptomycin concentrations, consistent
with the hypothesis that cells establish independently (main experi-
ment, Fig. 3B, and repeat experiments, SI Appendix, Fig. S5). More
precisely, the null model did not show significant deviance from the
observed proportion of populations that grew (according to the
likelihood ratio test), and thus we accept it as a parsimonious ex-
planation for the data. Furthermore, we obtain estimates of relative
establishment probability, ~pc, at 1/16 and 1/8 ×MICR similar to those
from the previous seeding experiments (SI Appendix, Table S2).
To summarize, the probability of culture growth at any given
streptomycin concentration depends on inoculum size, according
A B
Fig. 2. Establishment probability of single PA01:Rms149 streptomycin-
resistant cells, estimated from seeding experiments. (A) Visual representa-
tion of the growth data, indicating the number of replicate cultures (out of
96) that grew in each test condition up to 3 d postinoculation. (B) Estimated
relative per-cell establishment probability

~pc

, scaled by the probability in
streptomycin-free medium, as a function of streptomycin concentration,
scaled by the standard MIC value of the resistant strain (MICR = 2,048 μg/mL;
SI Appendix, Table S1). Results are shown for two separate experiments.
Plotted points indicate the maximum-likelihood estimate of ~pc, and error
bars indicate the 95% confidence interval, using the fitted model selected by
the likelihood ratio test (experiment 1: model B′, fixed environmental effect;
experiment 2: model C′, the null model [Eq. 1]. Both of these models pool
data across three inoculation densities; see SI Appendix, Text, section 10, for
details). Significance of the streptomycin effect is determined by fitting a
generalized linear model to the population growth data (n.s.: not signifi-
cant, P > 0.05; **P = 0.01 in experiment 1, P = 2e-7 in experiment 2, and P =
2e-8, pooling both experiments; ***P < 2e-16 in both experiments; see SI
Appendix, Text, section 14.1, for full results).
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to a simple quantitative relationship. Our experimental data are
consistent with a simple stochastic model in which cells behave
independently, such that a fixed per-cell establishment proba-
bility can explain our growth data across inoculum sizes. That is,
cells are not “more susceptible” to streptomycin at lower inoc-
ulum sizes, but rather, culture growth is less likely to be observed
simply because fewer cells are available to establish, and not all
cells succeed. In turn, the minimal concentration of streptomycin
required to prevent growth in a given proportion of replicate
cultures (i.e., the observed MIC) increases with inoculum size.
Sub-MICR Streptomycin Concentrations Induce Resistant Cell Death and
Extend Lag Phase. We hypothesized that resistant cells sometimes
failed to establish in our seeding experiments because exposure to
streptomycin compromised cell division rate and/or viability. As
a simple test of this idea, we measured the relative abundance of
dead cells in cultures of the resistant strain grown at sub-MICR
concentrations of streptomycin. We found that the fraction of
dead cells after 7 h of treatment, as determined by propidium
iodide staining, increased from an average of 3 to 4% in
streptomycin-free conditions to >20% at 1/8 × MICR strepto-
mycin (Fig. 4A and SI Appendix, Fig. S6 and Table S3). Note that
this is a conservative measure of cell death, because this assay
only detects cells that have compromised membrane perme-
ability, and not, for example, cells that have already lysed. Fur-
thermore, this assay provides only a snapshot in time.
To gain further insight into how sub-MICR streptomycin impacts
the population dynamics of the resistant strain, we quantified viable
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Fig. 3. Inoculum size effects on MIC and probability of population growth of the resistant PA01:Rms149 strain in streptomycin. (A) MIC as a function of
inoculum size. Cultures were inoculated with PA01:Rms149 at four different inoculum sizes. MIC was evaluated as the minimal tested streptomycin con-
centration that prevented detectable growth up to 3 d postinoculation; a qualitatively similar pattern arose if growth was evaluated at 20 h (SI Appendix, Fig.
S2). The y axis is scaled by the MIC of this strain at standard inoculation density (MICR). The points represent six replicates at each inoculum size, with the line
segments indicating their median. (B) Null model of the inoculum size effect (Eq. 1) fit to culture growth data. Probability of population growth (pw) is plotted
as a function of effective mean inoculum size (Neff , calibrated by the results in streptomycin-free media; SI Appendix, Fig. S4). Black: streptomycin-free; red:
streptomycin at 1/16 ×MICR; blue: 1/8 ×MICR. These results are based on growth in streptomycin up to 5 d postinoculation; see SI Appendix, Text, section 15,
for results at 3 d postinoculation. Points indicate the proportion of replicate cultures showing growth, i.e., the maximum-likelihood estimate (MLE) of pw in
the full model, with error bars indicating the 95% confidence interval (CI). The solid line shows the best fit of the null model (i.e., Eq. 1 parameterized with the
MLE of ~pc), and the shaded area corresponds to the 95% CI. According to the likelihood ratio test, the null model deviance from the full model is not sig-
nificant at any streptomycin concentration (streptomycin-free: P = 0.55; 1/16 × MICR: P = 0.28; 1/8 × MICR: P = 0.71; see SI Appendix, Text, section 15, for
full results).
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Fig. 4. Effects of sub-MICR streptomycin treatment on PA01:Rms149 resistant cell dynamics. (A) Proportion of dead cells after 7 h in sub-MICR streptomycin.
The proportion of dead cells in streptomycin-treated cultures was estimated using live–dead staining and flow cytometry. Points represent six independent
treatment replicates at each concentration, and line segments indicate their mean. Differences from the streptomycin-free control cultures were assessed
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replicates. Viable cell numbers were estimated by plating undiluted culture samples; plots are truncated when colonies became too dense to count. Sig-
nificance of each streptomycin concentration compared to the streptomycin-free control was assessed by a post hoc Dunnett’s test (n.s.: not significant, P =
0.87; *P = 4e-4; **P < 1e-4).
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cell density over the first few hours after inoculation into streptomycin-
containing media. Cultures were inoculated with ∼100 cells in
this experiment, to ensure that cell numbers were low enough for
demographic stochasticity to be relevant, yet large enough to be
detectable using conventional plating methods.
We found that streptomycin treatment has a significant effect
on the growth of resistant cultures (ANOVA, main effect: P < 2e-16),
and this effect varies over time (ANOVA, interaction term: P < 2e-16;
Fig. 4B and SI Appendix, Fig. S7). Following inoculation, cultures
exhibited a lag phase of ∼2 h. Control cultures in streptomycin-free
media then began to grow exponentially. The lowest tested con-
centration of streptomycin (1/32 ×MICR) had no significant effect
on these dynamics (Dunnett’s test: P = 0.87); however, 1/16 ×
MICR was already sufficient to slow growth (P = 4e-4). Nonethe-
less, all replicate cultures (n = 48 per concentration) eventually
grew, as detected by OD. Meanwhile, higher doses of streptomycin
(1/8 × or 1/4 × MICR) had dramatic effects on growth dynamics
(P < 1e-4), with cultures exhibiting an extended lag phase of at
least 7 to 8 h, in which viable cell density initially declined. After
further incubation (up to 3 d), 25% of cultures (15/60) exposed to
1/8 × MICR eventually showed growth, while the remaining 75%
(45/60) failed to reach detectable OD. At 1/4 × MICR, no viable
cells were detected in most cultures from 4 h on, and only 1/60
cultures reached detectable OD within 3 d.
In summary, sub-MICR streptomycin treatment has the effect
of extending the lag phase, before cultures eventually either grow
to saturation or die out. Failure to grow can be explained by
significantly elevated cell death rates beginning at 1/16 × MICR,
which can lead to stochastic loss of initially small populations.
Stochastic Establishment Is Recapitulated for a Clinically Relevant
Antibiotic and Resistance Plasmid. If the frequent failure of resis-
tant cells to establish surviving populations at antibiotic doses
well below their MIC is a general phenomenon, it would have
important implications for understanding de novo emergence of
resistance during antibiotic treatment. To check that our result was
not driven by the specific choice of antibiotic or resistance mecha-
nism, we repeated the key seeding experiment using a P. aeruginosa
PA01 strain carrying a recently isolated multidrug resistance plas-
mid, PAMBL2 (35, 36), that confers resistance to meropenem
through the blavim-1 carbapenemase. Carbapenems are an important
treatment option for serious infections caused by Gram-negative
bacterial pathogens (37), and resistance is of current clinical con-
cern (38, 39); carbapenem-resistant P. aeruginosa has been identi-
fied as a “critical priority” for new antibiotic development by the
World Health Organization (40). In agreement with our previous
findings, the establishment probability of PA01:PAMBL2 cells de-
clined at concentrations of meropenem well below this strain’s
MICR (SI Appendix, Table S1), reaching ∼5% at 1/8 ×MICR, while
no establishment was observed at 1/4 × MICR (Fig. 5 and SI Ap-
pendix, Table S4). This result demonstrates that the stochastic loss
of resistant cells is not unique to our primary model system of
PA01:Rms149 in streptomycin.
The Sensitive Population Modulates Probability of Establishment of
Resistant Cells. So far, we focused on the direct effects of antibi-
otics on resistant cells by conducting experiments with monocul-
tures of resistant strains. However, de novo resistance will actually
arise within a sensitive population, by mutation or transfer of a
mobile genetic element into a sensitive cell. Moreover, antibiotic
treatment will only begin in clinical settings once the total path-
ogen population is large enough to cause symptoms. We therefore
asked whether the presence of a large sensitive population affects
the establishment of initially rare resistant cells during anti-
biotic treatment, returning to PA01 (sensitive) and PA01:Rms149
(streptomycin-resistant) as a model system.
We expect the sensitive population and the antibiotic to have
interacting effects on establishment of resistance. In particular,
at sufficiently low antibiotic concentrations, a sensitive strain is
generally expected to outcompete a resistant strain due to the
fitness cost associated with resistance (4, 18). We confirmed this
expectation in our experimental system using a standard com-
petition assay, where both strains start from large inoculum sizes
(SI Appendix, Figs. S8–S10 and Table S5). We found that the
sensitive strain is favored up to a minimum selective concen-
tration (MSC) between 1 and 2 μg/mL streptomycin (equivalent
to 1/32 to 1/16 × MICS, or 1/2,048 to 1/1,024 × MICR), in
agreement with previous results for these strains (41). We hy-
pothesized that competitive suppression by the sensitive strain
would reduce absolute fitness of the resistant strain (5) and
hence prevent its establishment at streptomycin concentrations
below the MSC.
As a simple test of this idea, we modified the seeding exper-
iment to inoculate very few resistant cells into a large sensitive
population. Since bacterial densities in clinical infections can
vary widely (6, 42), we inoculated the sensitive strain at two
different densities: ∼5 × 105 CFU/mL (as in a standard MIC
assay; labeled “low”) and 5 × 107 CFU/mL (labeled “high”). The
resistant strain was seeded, with mean inoculum size on the or-
der of one cell per culture, immediately thereafter.
As hypothesized, we found that the presence of the sensitive
population (at either density) abolished establishment of resis-
tant cells in the absence of streptomycin (Fig. 6 and SI Appendix,
Fig. S11 and Table S6). Meanwhile, at streptomycin concentra-
tions above the MSC (1/256 to 1/8 ×MICR, or 1/4 to 8 ×MICS),
adding the sensitive population at low density had a negligible
effect on the probability of establishment of resistant cells. At
high density, the sensitive population also had negligible effects
on establishment of resistance at streptomycin concentrations up
to 1/16 ×MICR (4 ×MICS). However, at 1/8 ×MICR (8 ×MICS),
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Fig. 5. Estimated relative per-cell establishment probability of the
PA01:PAMBL2 meropenem-resistant strain as a function of meropenem
concentration. Concentration is scaled by the standard MIC of this strain in
meropenem (MICR = 512 μg/mL; SI Appendix, Table S1). Plotted points in-
dicate the maximum-likelihood estimate of ~pc, and error bars indicate the
95% confidence interval, using the fitted model selected by the likelihood
ratio test (model C′, the null model [Eq. 1], which pools data across two
tested inoculation densities). Significance of the meropenem effect is de-
termined by fitting a generalized linear model (GLM) to population growth
data (n.s.: not significant, P > 0.05; *P = 0.02; ***P < 2e-16; see SI Appendix,
Text, section 14.2, for full results). The 1/4 × MICR meropenem result was
excluded from the GLM because zero replicates established.
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the presence of a high-density sensitive population increased the
establishment probability from near zero to 65%. To confirm and
further probe the extent of this apparent protective effect, we
repeated the experiment over a higher range of streptomycin
concentrations. The boost in establishment probability was re-
peatable and highly significant at 1/8 ×MICR (Wilcoxon rank-sum
test, high- vs. zero or low-density sensitive: P < 5e-8 in both ex-
periments). However, at 1/4 × MICR (16 × MICS), an apparent
slight boost in establishment probability was nonsignificant, and by
1/2 × MICR (32 × MICS) the effect was abolished. Thus, a suffi-
ciently dense sensitive population can extend the range of strep-
tomycin concentrations at which the resistant strain is likely to
emerge, but does not change the qualitative pattern of stochastic
establishment.
Discussion
In order for resistance to emerge de novo, not only must a resis-
tance gene arise in a bacterial population by mutation or horizontal
gene transfer; this first resistant cell must also successfully expand
to form a large population. Since any individual cell may fail to
replicate, particularly in challenging environmental conditions, the
expansion of newly arisen resistant strains is not guaranteed. Our
results clearly demonstrate the significance of demographic sto-
chasticity in the de novo emergence of resistance, at antibiotic
concentrations well below the resistant strain’s MIC (MICR).
We empirically demonstrated the importance of stochasticity
with a simple “seeding experiment” mimicking the growth of
clonal resistant lineages founded by single cells. First, to assess
the direct impact of antibiotics, we inoculated fresh antibiotic-
containing media with approximately one resistant cell per replicate
culture and quantified the per-cell probability of establishing a
detectable population. Strikingly, this establishment probability
dropped off at concentrations well below the MIC of the resis-
tant strain (MICR). For example, the establishment probability
of PA01:Rms149 was significantly reduced by streptomycin con-
centrations as low as 1/16 × MICR and dropped to <5% at 1/8 ×
MICR (Fig. 2). Resistant cells failed to establish viable populations
because of the toxic effects of exposure to sub-MICR concentra-
tions of antibiotics (Fig. 4) coupled with the inherently stochastic
nature of individual cell death and division. Importantly, we were
able to replicate our key finding of frequent stochastic loss using a
different, meropenem-resistant strain (PA01:PAMBL2; Fig. 5).
This demonstrated that our results are not limited to a particular
model system, but are also relevant to antibiotics used clinically to
treat P. aeruginosa infections (37). We expect the qualitative
finding of stochastic loss to occur more generally, although the
quantitative similarity of results in the two systems tested here is
likely to be coincidental.
A natural follow-up question is, then, why some cells establish
and others do not. There are several possible mechanistic expla-
nations. First, it is conceivable that the inoculated resistant cells
that ultimately established carried additional genetic changes (ac-
quired during growth of the overnight preculture) conferring even
higher levels of resistance. In particular, unstable genetic changes
such as chromosome inversions (43) and gene amplifications (24)
can occur more frequently than point mutations, and amplifica-
tions have recently been identified as a major contributor to het-
eroresistance in bacterial populations (24, 44). However, at the
frequencies observed previously (∼10−7 to 10−5 for amplifications
conferring at least eightfold increase in MIC; ref. 24), this mech-
anism is expected to be negligible in our seeding experiments,
which inoculated only a few hundred cells in total across replicates.
Epigenetic changes have also been suggested as a mechanism for
slight decreases in susceptibility occurring at higher frequency
(∼1%) (45). Finally, there is a growing recognition that even ge-
netically identical bacteria exhibit phenotypic heterogeneity, which
could in particular affect individual cells’ susceptibility to antibi-
otics (46, 47). For example, those cells that established in our ex-
periments might have been in a particular metabolic state, or had
particularly high expression of the resistance gene. Investigating the
role of these mechanisms in the establishment of resistant lineages
would be an interesting direction for future work.
In clinical settings, antibiotic treatment will typically begin only
when the total population of pathogenic bacteria is large enough to
cause symptoms. Assuming that the patient was initially infected by
a sensitive strain, and given that resistance typically carries a fitness
cost in the absence of antibiotics (48, 49), we expect this bacterial
population will be predominantly antibiotic sensitive when treat-
ment begins. We therefore next asked how the presence of a large
sensitive population would combine with the above effects of an-
tibiotics to shape the establishment of resistant cells, again in the
streptomycin model system. As expected, establishment of resis-
tance was abolished in the absence of antibiotics (Fig. 6), pre-
sumably due to competitive suppression by the sensitive strain.
More interestingly, a sufficiently dense sensitive population (in-
oculated at ∼5 × 107 CFU/mL here) was able to shift the range of
concentrations at which resistance usually established upwards by
approximately twofold. We speculate that this apparent protection
is due to sensitive cells absorbing antibiotics, thus lowering their
concentration in the media (31, 50). A priori, one may have
expected outgrowth of resistant cells whenever antibiotic concen-
tration is below MICR, and hence for protection to be irrelevant.
However, in the stochastic regime of establishment, any increase in
the probability of individual cells surviving and dividing can criti-
cally impact the fate of a rare resistant lineage. We emphasize that,
although these experiments provide an initial proof of concept, a
complete investigation of the interacting effects of sensitive pop-
ulation density, antibiotic dose, and timing remains an important
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Fig. 6. Impact of a large sensitive population on the establishment proba-
bility of a resistant cell. The PA01:Rms149 resistant strain was seeded either
alone (black) or into a low-density (cyan) or high-density (orange) sensitive
PA01 population, across a range of streptomycin concentrations. Results are
shown from two separate experiments, testing different subsets of condi-
tions (experiment 1, data points in squares with solid line; experiment 2,
data points in circles with dashed line). Within each experiment, the esti-
mated relative establishment probability per resistant cell (~pc) in each con-
dition is normalized by the result for the resistant strain alone in
streptomycin-free media. Points indicate the maximum-likelihood estimate
of ~pc, and error bars indicate the 95% confidence interval, using the fitted
model selected by the likelihood ratio test (model C′, the null model [Eq. 1]
for both experiments). At streptomycin concentrations of particular interest,
the number of replicates in which the resistant strain established in the
presence of no or low-density sensitive (pooled where applicable) vs. high-
density sensitive was compared using a two-sided Wilcoxon rank-sum test,
with significance annotated on the plot (1/16 ×MICR: experiment 1, P = 0.17;
1/8 × MICR: experiment 1, P < 2.2e-16, and experiment 2, P = 4.8e-8; 1/4 ×
MICR: experiment 2, P = 0.042, not significant after Bonferroni correction);
see SI Appendix, Text, section 16, for further details.
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direction for future work. Importantly, however, our main message
continues to hold in the more realistic context of resistance
emerging within a large sensitive population: Stochastic loss of
resistant cells is frequent at antibiotic concentrations well below
MICR, despite the selective advantage of resistance in these
conditions.
The failure of resistant cells to establish successful lineages at
concentrations well below MICR illustrates the limitations of
population-based measures in explaining single-cell behavior. To
explain this effect rigorously, we quantified the probability of
outgrowth of a detectable resistant population at a fixed strepto-
mycin concentration, starting from inoculum sizes spanning three
orders of magnitude. We fit these data to a mathematical model
relating inoculum size to probability of population growth, under
the hypothesis that each cell in the inoculum behaves indepen-
dently (Eq. 1). This simple stochastic model, parameterized by the
per-cell probability of establishment, provides a good explanation
for inoculum size-dependent population growth in PA01:Rms149
(Fig. 3B). In the case of cell-to-cell heterogeneity in susceptibility,
the establishment probability should be interpreted as an average
across cells (SI Appendix, Text, section 10.1), or the proportion of
cells that establish at a given antibiotic concentration. Importantly,
however, this parameter is independent of inoculum size: that is,
individual cells are not “more susceptible” to antibiotic in smaller
populations. Instead, the cumulative effect of many cells, each
with a small chance of establishment (e.g., <5% at 1/8 ×MICR in
this system), virtually guarantees population growth from a suffi-
ciently large inoculum size, reconciling our results with the stan-
dard definition of the MIC. We thus emphasize that MIC is an
emergent property of a population of cells. We also note that the
inoculum size effect on MIC that we found here—a purely sto-
chastic phenomenon arising at low absolute numbers (in CFU)—is
distinct from the inoculum size effect already widely recognized in
the literature, which is seen at high cell density (in CFU/ml) and
attributed to various density-dependent mechanisms, such as titra-
tion or enzymatic inactivation of antibiotics (31, 32, 41, 51–54).
While there are hints of the former absolute-number effect in
earlier studies (33, 34), we provide a rigorous explanation in terms
of stochastic population dynamics.
This model also provides a simple way to predict whether
resistance will emerge during treatment from a preexisting sub-
population of resistant cells, derived from one or more mutations
occurring prior to the start of treatment. The mean inoculum size
in Eq. 1, representing the number of resistant cells inoculated
into antibiotic-containing media in our experiments, can be rein-
terpreted as the number of resistant cells present in an infection at
the start of treatment. Clearly, if the preexisting subpopulation is
sufficiently large, the probability of outgrowth during treatment
approaches 1 at sub-MICR antibiotic concentrations. However, if
resistance must first arise by de novo mutation or horizontal gene
transfer, the size of the resistant subpopulation may be small and
highly variable, following a form of the Luria–Delbrück distribu-
tion (55, 56). Eq. 1 provides a unified way of scaling from single-
cell to population behavior across this range of inoculum sizes. We
note that an identical relationship arises more generally in models
of evolutionary rescue, where adaptation prevents extinction of a
population facing severe environmental change (57) (see SI Ap-
pendix, Text, section 10.2, for further discussion).
Although the role of demographic stochasticity in the fate of
mutant lineages has long been recognized in theoretical pop-
ulation genetics, until very recently it had never been addressed
empirically (25). Our study joins a small handful of others that
have now experimentally quantified establishment probability from
single cells (26, 27, 58, 59), including two (26, 27) investigating es-
tablishment of bacterial cells in the presence of antibiotics. These
studies used different methods to ours (see SI Appendix, Text, sec-
tion 10.2, for a more detailed comparison) and did not discuss the
implications for emergence of antibiotic resistance. More broadly,
the concepts and statistical methods developed here are applicable
to a variety of situations where growth depends on success of rare
cells and is thus highly stochastic, for instance the establishment of
productive infection in a host following pathogen transmission (60),
the onset of invasive bacterial infections (61), the outgrowth of
bacteria in food products from small initial contaminants (62), or
the establishment of metastases from cancerous tumors (63).
In summary, our study highlights the stochastic nature of de
novo emergence of antibiotic resistance. In a practical sense, this
stochasticity implies that to accurately assess the risk of resistance
emerging, we must evaluate not only mutation rates, but also the
probability that resistant mutants escape extinction when rare (6),
which will depend on antibiotic dosing. Our results underscore the
importance of understanding the impact of antibiotic treatment on
the single-cell level (see also ref. 45) and caution against the ex-
trapolation of population-level measures. While a positive selection
coefficient is a necessary condition for resistance to outcompete an
initially prevalent sensitive strain, it does not guarantee establish-
ment when rare; indeed, we showed that single resistant cells are
frequently lost at antibiotic concentrations at which they are se-
lectively favored. In cases where MICR lies above the maximum
tolerable dose (22), our results have the promising message that
lower concentrations may be sufficient to prevent de novo emer-
gence of resistance with high probability. Use of lower antibiotic
doses could have further benefits, such as reducing release of an-
tibiotics into the environment (64) and, in the case of antibiotics
that have mutagenic effects, perhaps reducing the chance of a
resistance mutation arising in the first place (ref. 65; see, how-
ever, ref. 66). The possibility of stochastic extinction of small
resistant populations opens the door to considering alternative
antibiotic dosing strategies, and an important direction for future
work will be to evaluate the establishment probability of resistant
cells in time-varying antibiotic concentrations reflecting realistic
pharmacokinetics (cf. ref. 67).
Materials and Methods
Further details of experimental protocols, data processing, mathematical
models, and statistical methods and results are provided in SI Appendix, Text.
Bacterial Strains, Media, and Culture Conditions.
Bacterial strains. The majority of our experiments, in streptomycin, were
conducted with a set of Pseudomonas aeruginosa PA01 strains studied
previously (41). The streptomycin-sensitive and -resistant strains are chro-
mosomally isogenic, while resistant strains additionally carry the clinically
derived, nonconjugative plasmid Rms149 (68), which is stably maintained in
PA01 at approximately two copies per cell (69). Streptomycin resistance is
conferred by the aadA5 gene on Rms149, which codes for an enzyme that
adenylates streptomycin (70). Both plasmid carriers (resistant) and noncar-
riers (sensitive) are available with either YFP or DsRed chromosomal fluo-
rescent markers or with no marker (41). The live–dead staining experiment
was conducted with the unlabeled resistant strain. All other experiments
reported in the main text were conducted with the YFP-labeled resistant
strain and, where applicable, the DsRed-labeled sensitive strain. We chose
this pairing because YFP provides a stronger signal, facilitating detection of
the resistant strain in mixed cultures. Previous work with these strains sug-
gests that the two fluorescent labels have similar fitness effects (41), and we
confirmed that the label had no substantive effect on the MIC values of the
sensitive strain (SI Appendix, Text, section 2.1). For the seeding experiment
in meropenem, we transformed the plasmid PAMBL2 into the same PA01-
YFP background (SI Appendix, Text, section 1). This plasmid, isolated in 2007
from a P. aeruginosa clinical isolate (35), confers meropenem resistance
through three copies of the blaVIM-1 gene, which codes for a metallo-β-lac-
tamase (35, 36). It is nonconjugative (36) and stably maintained in PA01 at an
average of two to three copies per cell (69). MIC values of all relevant
strain–antibiotic pairs are reported in SI Appendix, Table S1.
Media and antibiotics. We cultured bacteria in LB broth containing 5 g/L NaCl
(Sigma-Aldrich; product no. L3022). To assess CFU, we plated on LB agar, Vegitone,
containing 5 g/L NaCl and 15 g/L agar (Sigma-Aldrich; product no. 19344). Strep-
tomycin was prepared from streptomycin sulfate salt (Sigma-Aldrich; product no.
S6501), andmeropenemwasprepared frommeropenem trihydrate (Santa Cruz
Biotechnology; product no. SC-485799). Stocks prepared in water were stored
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according to supplier directions and added to media on the day of experi-
ments. When high antibiotic concentrations were required, stocks were in-
stead prepared directly in LB on the day of experiments to avoid excessive
dilution of the media with water. Bacterial cultures were diluted in PBS pre-
pared from tablets (Sigma-Aldrich; product no. P4417). Treatment cultures
were set up with 90%media plus 10% inoculating culture by volume; thus, the
final concentrations of LB and antibiotics in the treatments are 90% of the
prepared media values denoted on plots.
Culture conditions. All cultures were incubated at 37 °C, shaking at 225 rpm.
Overnight cultures were inoculated directly from freezer stocks into 2 mL of
LB in 14-mL culture tubes and incubated for ∼16 h. Overnight cultures were
then diluted in PBS and used to inoculate treatment plates. Unless otherwise
noted, experimental treatments were conducted in 200-μL cultures in flat-
bottom 96-well microtiter plates.
Scoring culture growth. In all experiments, we evaluated culture growth by
measuring OD595 using a BioTek Synergy 2 plate reader, at room tempera-
ture. Lids on microtiter plates were briefly removed in a nonsterile envi-
ronment for the reading; comparison to controls mock-inoculated with PBS
indicated that contamination was rare (see SI Appendix, Text, for detailed
quantification in each experiment). We set a threshold of OD595 > 0.1 to
score as growth, whereas background OD in media-only controls was typi-
cally below 0.05. Final readings at 3 d postinoculation were used for data
analysis unless otherwise noted. By this time, growth had typically stabilized,
with OD much higher than the threshold.
MIC Assays. Standard MIC values for all applicable strain–antibiotic pairs
(i.e., resistant Rms149-carrier against streptomycin; resistant PAMBL2-carrier
against meropenem; sensitive noncarrier against both antibiotics) were de-
termined under our culture conditions using the broth microdilution
method. Overnight cultures were diluted 103-fold and inoculated into
antibiotic-containing media at 20 μL/well on 96-well test plates. This dilution
factor consistently yielded an inoculation density close to 5 × 105 CFU/mL, in
accordance with standard protocol (3); actual density was estimated by
plating. Test plates were incubated and scored for growth at ∼20 h [as per
standard protocol (3)], 2 d, and 3 d postinoculation. For consistency with
growth scoring in seeding experiments, the standard MIC values (MICS and
MICR) used to scale antibiotic concentrations on plot axes are based on re-
sults at 3 d. Consensus MIC values of all tested strain–antibiotic pairs, at both
20 h and 3 d, are reported in SI Appendix, Table S1, with results of individual
replicates reported in SI Appendix, Text, section 2.1. For the YFP-labeled
Rms149-carrying resistant strain, an additional MIC assay in streptomycin
was conducted, varying inoculum size (Fig. 3A). Here, inoculations were
conducted with overnight culture diluted 103-, 104-, 105-, and 106-fold (see SI
Appendix, Text, section 2.2, for details).
Seeding Experiments: Resistant Strains in Isolation.
Experimental protocol. A highly diluted overnight culture of the YFP-labeled
resistant strain (Rms149- or PAMBL2-carrier) was inoculated at 20 μL/well
into antibiotic-containing media on 96-well test plates. For experiments with
PA01:Rms149 screening across many streptomycin concentrations (Fig. 2), we
used three dilution factors (4 × 107-, 8 × 107-, and 1.6 × 108-fold), each to
inoculate 96 replicate wells at each concentration. To test the null model of
the inoculum size effect (Fig. 3B), we screened fewer streptomycin concen-
trations across a larger number of dilution factors (5 in streptomycin-free
conditions and 6 to 10 in each streptomycin concentration), each with 54
replicates. These dilution factors were chosen differently for each strepto-
mycin concentration to capture the range over which the proportion of
replicate cultures showing growth increased from near 0 to near 1. For the
experiment with PA01:PAMBL2 in meropenem (Fig. 5), we used two dilution
factors (5 × 107- and 2 × 108-fold), each with 96 replicates per concentration.
In all cases, test plates were incubated and scored for growth after ∼1, 2, and
3 d; for the null model test, incubation and readings were continued up to
5 d to confirm stabilization of growth. See SI Appendix, Text, sections 4 and
5, for further details.
Model fitting. The number of replicate cultures showing growth by 3 d (or,
additionally, by 5 d for the null model test), at each inoculating dilution factor
and antibiotic concentration, was used for subsequent model fitting. To
estimate single-cell establishment probability and evaluate the null model of
the inoculum size effect, likelihood-based methods were used to fit a sto-
chastic model of population growth to these data (see below, Mathematical
Model of Establishment). In addition, to evaluate the effect of antibiotic
concentration on establishment, generalized linear models were fit to data
from the seeding experiments screening across streptomycin (Fig. 2) or
meropenem (Fig. 5) concentrations. Using the built-in R function “glm,”
growth data were treated as binomial, with inoculating dilution factor and
antibiotic concentration taken as explanatory variables, applying the com-
plementary log-log link function (SI Appendix, Text, section 12).
Seeding Experiments: Resistant Strain in Presence of Sensitive Population.
Overnight culture of the DsRed-labeled PA01 sensitive strain was diluted
5-fold to obtain the “high-density” inoculating culture, and (in the first
experiment only) further to 500-fold to obtain the “low-density” inoculating
culture. Overnight culture of the YFP-labeled PA01:Rms149 resistant strain
was diluted up to 5 × 107-fold and 2 × 108-fold. These cultures were inoc-
ulated as follows into media at various streptomycin concentrations on
96-well plates. Pure sensitive control cultures (24 replicates per test condi-
tion) were inoculated with 10 μL/well of the appropriate diluted culture plus
10 μL/well PBS. “Blank” wells to serve as background fluorescence controls
were inoculated with 20 μL/well PBS. Seeding test plates were first inocu-
lated with 10 μL/well of either PBS (for pure resistant control cultures), low-
density or high-density sensitive culture. The resistant strain was inoculated
at 10 μL/well immediately thereafter (all sensitive and resistant culture in-
oculations were completed within an hour). Seeding was conducted with 30
to 60 replicates per test condition and resistant dilution factor (see SI Ap-
pendix, Text, section 6, for details). All test plates were then incubated as
before, with OD595 and fluorescence (excitation: 500 ± 27 nm; emission:
540 ± 25 nm) measured at ∼1, 2, and 3 d postinoculation. Among wells
showing growth (OD > 0.1), we considered the YFP-labeled resistant strain
to have established if fluorescence exceeded 5 × 105 units, chosen by com-
parison to pure cultures. In each test condition, the number of replicates in
which resistance established was taken as data for model fitting, as in the
previous seeding experiments.
Fraction of Dead Cells by Live–Dead Staining. This experiment used the
PA01:Rms149 resistant strain with no fluorescent label, to avoid interfering
with the signal from the stains. We inoculated streptomycin treatment cul-
tures (six replicates per concentration) with 103-fold diluted overnight cul-
ture, as in the standard MIC assay. After 7 h of treatment, we diluted test
cultures 100-fold and stained with thiazole orange and propidium iodide
(BD Cell Viability Kit; product no. 349483). In parallel, we diluted and stained
media and heat-killed cultures as controls. We sampled 50 μL per diluted
culture using flow cytometry (BD Accuri C6 Flow Cytometer with fast fluidics,
discarding events with forward scatter FSC-H < 10,000 or side scatter SSC-H <
8,000). The staining and flow cytometry steps were carried out in groups
containing one replicate per concentration plus controls, to avoid poten-
tially toxic effects of stain exposure over prolonged times (SI Appendix, Text,
section 7). To better discriminate cells from background in the flow cytom-
etry data, we first gated on events according to forward and side scatter
before defining clusters of dead (membrane-compromised) and intact cells
based on fluorescence; see SI Appendix, Text, section 7 and Fig. S6, for
details.
Viable Cell Density Dynamics. Using the YFP-labeled PA01:Rms149 strain, we
tracked the number of viable cells over time in streptomycin-free media (12
replicates per time point) and at 1/32, 1/16, 1/8, and 1/4 ×MICR streptomycin
(6 replicates per time point). An independent test plate was used for sam-
pling at each time point. Lower (set A) and higher (set B) streptomycin
concentrations were split across separate plates and sampled at different
times. Cultures were inoculated with 20 μL of 5 × 105-fold diluted overnight
culture. At each sampling time, we plated 5 × 4-μL spots of undiluted cul-
tures (10% sampling by volume). The number of viable cells was estimated
from total colony count following incubation. Comparison of streptomycin-
free controls from both sets (A and B) indicated that the plate set effect was
nonsignificant (ANOVA: P = 0.10); thus, controls were pooled for further
analysis of the streptomycin effect (see SI Appendix, Text, section 8, for
further details).
Mathematical Model of Establishment.
Model. We denote by pw the probability that a small number of inoculated
cells grows into a large population, i.e., that the culture reaches detectable
OD as described above. Among a set of n independent replicates, the
number of cultures showing growth is thus described by a binomial(n,pw)
distribution.
In the “null” model, similar to previous work (57, 60), a simple expression
for pw is derived under the assumptions that 1) the number of cells in the
inoculum is Poisson-distributed with mean N; 2) each cell, independently,
establishes a surviving lineage with probability pc, which depends only on
antibiotic concentration x; and 3) culture growth is observed, provided at least
one cell establishes a surviving lineage. Then the probability of observing
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culture growth, as a function of mean inoculum size and antibiotic concen-
tration, can be written as follows (SI Appendix, Text, section 10):
pw (N, x) = 1 − e−Npc (x) = 1 −   e−Neff ~pc (x). [1]
In the second step, we have rewritten the expression in terms of the “ef-
fective mean inoculum size,” Neff = Npc(0), which is the mean number of
established lineages in the absence of antibiotics; and the “relative estab-
lishment probability,” ~pc(x) =   pc(x)=pc(0). Although we expect that pc(0) is
close to 1, N and pc(0) play indistinguishable roles in this model, so that in
practice we can only estimate their product. This definition of effective in-
oculum size based on cells that grow in benign conditions is similar to the
usual quantification of “viable” cells according to successful formation of a
colony; we simply assess growth in liquid rather than on solid medium.
Scaling up Neff by the dilution factor applied to the inoculating culture, we
have an estimate of bacterial density in this culture, equivalent to the his-
torical “most probable number” method (71, 72). If cells are phenotypically
heterogeneous (i.e., vary in their propensity to establish), or if the individual
units in the inoculum are actually clumps of cells, then pc should be inter-
preted as the mean establishment probability among individuals (SI Ap-
pendix, Text, section 10.1).
More generally, we need not assume that cells establish independently. If
we suppose simply that the number of established lineages is Poisson-
distributed with some mean α (which is supported empirically by the distri-
bution of CFU counted in highly diluted cultures; SI Appendix, Fig. S1), we
have the following relationship:
pw (N, x) = 1 − e−α(N, x), [2]
where α, and hence pw, have an arbitrary dependence on mean inoculum
size and antibiotic concentration. In the statistical “full model,” we estimate
a distinct pw (or equivalently α, by the one-to-one mapping in Eq. 2) in each
test condition. Relative establishment probability is then generally defined
by ~pc(N, x) = α(N, x)=α(N, 0). Nested models, including the null model above,
make additional assumptions about the form of α (see SI Appendix, Text,
section 10, for details).
Likelihood-based model fitting and comparisons. These stochastic models are fit
to experimental population growth data using likelihood-based methods (SI
Appendix, Text, section 11). Specifically, under each model, we obtain a
maximum-likelihood estimate and a 95% confidence interval (determined
by the range of parameter values that would not be rejected by a likelihood
ratio test at 5% significance level) on the parameter pw, which can be
transformed to an estimate for α. In the case of relative establishment
probability, ~pc(x) = α(x)=α(0), we use a profile likelihood confidence interval
accounting for the uncertainty in both numerator (i.e., results at antibiotic
concentration x) and denominator (i.e., results in antibiotic-free conditions).
The fit of nested models is compared using the likelihood ratio test (LRT) at
5% significance level, i.e., a χ2 test on model deviance with degrees of
freedom equal to the difference in number of fitted parameters between
the two models.
To test the null model of the inoculum size effect, we neglect any ex-
perimental error in preparing overnight culture dilutions, and assume that
mean inoculum size N is inversely proportional to the applicable dilution
factor. Effective mean inoculum size, Neff , is estimated by fitting Eq. 1 to
population growth data in antibiotic-free media. Per-cell relative establish-
ment probability ~pc then remains as the single free parameter to fit at each
tested antibiotic concentration. The goodness of fit of the null model (Eq. 1)
is assessed for each test concentration separately, using the LRT to compare
it to the fit of the full model (Eq. 2).
All model fittingwas implemented in R, version 3.3.1 (The R Foundation for
Statistical Computing, 2016).
Data and Code Availability. Data generated in this study, as well as custom R
scripts for likelihood-based model fitting and comparisons, are deposited in
Dryad (DOI: 10.5061/dryad.12jm63xtb).
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